Invests primarily in biotechnology and biopharmaceutical companies worldwide with the objective of long-term capital growth. The strategy combines specialized sector expertise, fundamental research, and disciplined portfolio management to identify attractive opportunities across innovative and established segments of the sector.
Updated 2026-03-19